The US is the bigger Over The Counter (OTC) Antifungal market: $1.1 Bn against $201 Mn in 2023, about 5.2 times as large.
China grows faster: 5.3% a year, against 1.8%. The gap still grows from $849 Mn to $918 Mn by 2033.
Clinical research: 2 active trials in the US, 2 in China.
| Measure |  US |  China |
|---|---|---|
| Market size, 2023 | $1.1 Bn | $201 Mn |
| Market size, 2033 projected | $1.3 Bn | $337 Mn |
| Growth a year (CAGR) | 1.8% | 5.3% |
| Money added, 2023–2033 | $205 Mn | $136 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $3.07 | $0.14 |
| Active clinical trials | 2 | 2 |
| Full report | US report | China report |
Year by year, 2023 to 2033
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Over The Counter (OTC) Antifungal, US or China?
The US is the bigger Over The Counter (OTC) Antifungal market: $1.1 Bn against $201 Mn in 2023, about 5.2 times as large.
Which grows faster in Over The Counter (OTC) Antifungal, US or China?
China grows faster: 5.3% a year, against 1.8%. The gap still grows from $849 Mn to $918 Mn by 2033.
More Over The Counter (OTC) Antifungal comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.